1. Home
  2. BGLC

as of 06-04-2026 3:59pm EST

$2.30
+$0.02
+0.66%
Stocks Health Care Medical Specialities Nasdaq

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Founded: 2017 Country:
Malaysia
Malaysia
Employees: N/A City: KUALA LUMPUR
Market Cap: 4.9M IPO Year: 2019
Target Price: N/A AVG Volume (30 days): 10.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.23 EPS Growth: 45.78
52 Week Low/High: $1.92 - $15.19 Next Earning Date: 04-14-2026
Revenue: $7,424,911 Revenue Growth: -21.93%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -10.13 Index: N/A
Free Cash Flow: -1875353.0 FCF Growth: N/A

AI-Powered BGLC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 70.14%
70.14%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: